Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Pascal Biosciences Inc.US flagOther OTC
0.11
USD
+0.01
- -
4.20MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
CEO
John Kueber
Full Time Employees
2
Sector
Healthcare
Industry
Biotechnology
Address
4000 Mason Road Seattle WA United States of America 98195-2141
IPO Date
Feb 3, 2015
Business
Nevis Brands Inc., formerly Pascal Biosciences Inc., develops and licenses cannabis beverage brands across regulated markets and hemp-derived THC products in the United States. The company offers fast-acting, cannabis-infused beverages under its flagship Major brand, including 100mg THC single-serve shots in flavors such as Blueberry, Fruit Punch, and Blackberry Lemonade; hemp-derived THC options like Happy Apple, a low-dose 5mg beverage; and additional brands including Pearl, Utopia, Atomic Apple, Vertus, and Velvet Swing. These products target adult-use cannabis consumers through licensing agreements with manufacturers and distributors, emphasizing precise dosing, premium ingredients, and rapid onset effects within 10-20 minutes. Founded in 2013 and headquartered in Seattle, Washington, Nevis Brands operates primarily in the U.S. cannabis beverage sector, with nationwide reach for hemp-derived products and presence in regulated state markets including Washington, New Jersey, Oklahoma, Illinois, Missouri, Michigan, California, Nevada, New Mexico, and Arizona. In June 2023, the company rebranded from Pascal Biosciences Inc., a biotechnology firm focused on cancer therapies such as cannabinoid-based ST-403 for glioblastoma and B-cell targeted antibodies, to concentrate on cannabis beverages, completing the operational transition by fiscal year-end 2023 with reported revenues of $671,000. Recent expansions include licensing agreements for Major production in Missouri with Stash House (January 2024), Michigan with Emerald Canning Partners (November 2023), California with Blaze Life Holdings (October 2023), Illinois with Drecisco Farms (February 2024), and Oklahoma with Stash House Brands (November 2024); product launches in New Mexico (October 2025) and planned Arizona entry by November 2025; and Happy Apple distribution growth in North and South Carolina via new partnerships (May 2025). Over 5 million bottles of Major have been sold since its 2019 Washington launch, with ongoing production in New Jersey and Oklahoma, and quarterly revenues reaching $395,876 by Q4 2023 from royalties in five states.

Company News

APIChat